To test this hypothesis, we introduced PKCι siRNAs into both PRKCI-amplified and non-amplified ovarian cancer cell lines (sequences in Fig. 3a) and their silencing effect was confirmed by western blotting (Fig. 3b). The gene discussed is PRKCI; the disease is ovarian carcinoma.